The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma

Haematologica

Volumn 92, Issue 2, 2007, Pages

  Koster, Ad ^a   Tromp, Hedwig A ^a   Raemaekers, John M M ^a   Borm, George F ^a   Hebeda, Konnie ^a   MacKenzie, Marius A ^a   Van Krieken, Joannes H J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Follicular lymphoma; Mib 1; Prognosis; Proliferation

Indexed keywords

ALPHA2B INTERFERON; CYCLOPHOSPHAMIDE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR CELL; BIOPSY; DISEASE FREE SURVIVAL; GENETICS; LYMPH NODE; MIDDLE AGED; PATHOLOGY; TIME; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPH NODES; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85047279202     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10384     Document Type: Article

References (25)

1. Lopez-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994; 12:1343-8.
2. Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258-65.
3. Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, et al. Multivariate-analysis of prognostic factors in stage-Iv follicular low-grade lymphoma - a risk model. J Clin Oncol 1991;9:762-9.
4. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1983;1:187-92.
5. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee MeetingAirlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835-49.
6. Rodriguez J, McLaughlin P, Hagemeister FB, Fayad L, Rodriguez MA, Santiago M, et al. Follicular large cell lymphoma: An aggressive lymphoma that often presents with favorable prognostic features. Blood 1999;93:22027.
7. Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D, et al. Follicular large-cell lymphoma treated with intensive chemotherapy: An analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. J Clin Oncol 1997; 15: 1654-63.
8. Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Muller-Hermelink HK, et al. Grading of follicular lymphoma: diagnostic accuracy, reproducibility, and clinical relevance. Modern Pathology 1998;11:142A.
9. Metter GE, Nathwani BN, Burke JS, Winberg CD, Mann RB, Barcos M, et al. Morphological subclassification of follicular lymphoma - variability of diagnoses among hematogathologists, a Collaborative Study etween the Repository Center and Pathology Panel for Lymphoma Clinical-Studies. J Clin Oncol 1985; 3:25-38.
10. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
11. Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 1988; 71:1157-60.
12. Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, et at. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 1994; 83:1460-6.
13. Mandigers CM, Meijerink JP, Mensink EJ, Tonnissen EL, Hebeda KM, Bogman MJ, et al. Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood 2001; 98:940-4.
14. Jaffe ES, Harris NL, Stein H, Vardiman J. Tumours of haematopoietic and lymphoid tissues, WHO Classification of Tumours. Lyon: IARC Press. 2001.
15. Cibull ML, Heryet A, Gatter KC, Mason DY. The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas. J Pathol 1989;158:189-93.
16. Llanos M, Alvarez-Arguelles H, Aleman R, Oramas J, Diaz-Flores L, Batista N. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma. Med Oncol 2001;18:15-22.
17. Martin AR, Weisenburger DD, Chan VC, Ruby EI, Anderson JR, Vose JM, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995;85: 3671-8.
18. Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS. Cell-proliferation in non-Hodgkin's lymphomas - digital image-analysis of Ki-67 antibody staining. Am J Pathol 1989;134:327-36.
19. Sebo TJ, Roche PC, Witzig TE, Kurtin PJ. Proliferative activity in non-Hodgkin's lymphomas - a comparison of the bromodeoxyuridine labeling index with Pcna immunostaining and quantitative image-analysis. Am J Clin Pathol 1993;99: 668-72.
20. Tominaga K, Yamaguchi Y, Nozawa Y, Abe M, Wakasa H. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67. Hematol Oncol 1992;10:163-9.
21. Weiss LM, Strickler JG, Medeiros LJ, Gerdes J, Stein H, Warnke RA. Proliferative proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol 1987;18:1155-9.
22. Czader M, Mazur J, Pettersson M, Liliemark J, Stromberg M, Christensson B, et al. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer 1996;77:1180-8.
23. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 2005;29: 1490-6.
24. Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005; 105: 1417-23.
25. Saito B, Shiozawa E, Yamochi-Onizuka T, Adachi D, Nakamaki T, Tomoyasu S, et al. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression. Pathol Intern 2004; 54:667-74.